| Fri, Dec 11, 2009 | | | Facet Rejects Biogen Again Zacks.com (Fri, Dec 11)
| | Thu, Dec 10, 2009 | | | Facet rejects Biogen Idec offer at bizjournals.com (Thu, Dec 10)
| | Mon, Dec 7, 2009 | | | Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting PR Newswire (Mon, Dec 7)
| | Fri, Dec 4, 2009 | | | Our Final Offer (Maybe)! That's a FACT! at Motley Fool (Fri, Dec 4)
| | Thu, Dec 3, 2009 | | | UPDATE - Biogen ups offer for Facet Biotech to $17.50/share at Reuters (Thu, Dec 3)
| | Mon, Nov 16, 2009 | | | TRUBION PHARMACEUTICALS, INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online (Mon, Nov 16)
| | | Trubion shakes up management at bizjournals.com (Mon, Nov 16)
| | | Trubion Pharmaceuticals, Inc. Announces Transition in Company Leadership PR Newswire (Mon, Nov 16)
| | Wed, Nov 11, 2009 | | | Trubion Announces Acceptance of Two Presentations on Its TRU-016 Product Candidate at the 2009 ASH Annual Meeting PR Newswire (Wed, Nov 11)
| | | TRUBION PHARMACEUTICALS, INC Financials EDGAR Online Financials (Wed, Nov 11)
| | Sun, Nov 8, 2009 | | | New Star Analyst Rankings for Trubion Pharmaceuticals, Inc. StarMine (Sun, Nov 8)
| | Thu, Nov 5, 2009 | | | Trubion loses $6.2 million in Q3 at bizjournals.com (Thu, Nov 5)
| | | TRUBION PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online (Thu, Nov 5)
| | | TRUBION PHARMACEUTICALS, INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Thu, Nov 5)
| | | Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results PR Newswire (Thu, Nov 5)
| | | Q3 2009 TRUBION PHARMA INC Earnings Release - After Market Close CCBN (Thu, Nov 5)
| | Thu, Oct 29, 2009 | | | Trubion Announces Dates for Third Quarter and Nine Months 2009 Earnings Conference Call PR Newswire (Thu, Oct 29)
| | Mon, Oct 26, 2009 | | | Trubion Announces Upcoming Presentation at 8th Annual BIO Investor Forum PR Newswire (Mon, Oct 26)
| | Mon, Oct 19, 2009 | | | Trubion says rheumatoid arthritis drug study goes well at bizjournals.com (Mon, Oct 19)
| | | Trubion Pharmaceuticals, Inc. Reports Positive Data from Phase 2b Re-treatment Study of TRU-015 PR Newswire (Mon, Oct 19)
| Add TRBN News to My Yahoo!:

| |
|